-
Additional file 2 of Risk factors for the critical illness in SARS-CoV-2 infe...
Additional file 2: Supplementary Table S2. Performance of different models for predicting critical illness in SARS-CoV-2 infection. -
dedup_wf_001--1d0ce5e2ca085582ff8bb30ed24e7af6
Table S1. Description of data: Studies reporting non-pharmacological treatment efficacy in patients with mild COPD. (PDF 17 kb) -
Additional file 1: of Genetic characterization and molecular survey of Babesi...
a. Alignment of partial nucleotide sequences of rap-1a gene from different Chinese isolates. FJ2: B. bovis rap-1a isolate Fujian 2; GS: B. bovis rap-1a isolate Guansu; FJ1: B.... -
Additional file 2: of Available, Bed-sided, Comprehensive (ABC) score to a di...
Comparison of the two patient cohorts. (PDF 149Â kb) -
Additional file 1: of Patientsâ ability to read and understand dosing instruc...
Patientsâ data collection sheet (English) in hospital and community pharmacy settings. (PDF 844 kb) -
dedup_wf_001--8ad2ed0b97141597ef69887e5bf4caf7
Resazurin reduction by J774A.1 (A) and A549 (B) cells exposed to particles. Average fold-effect (FE) over control ± standard error values are shown (n = 5). ATP content of... -
Additional file 2: Figure S1. of Development of an integrated approach for co...
Resazurin reduction by J774A.1 (A) and A549 (B) cells exposed to particles. Average fold-effect (FE) over control ± standard error values are shown (n = 5). ATP content of... -
dedup_wf_001--e807a92434f8fac63fd58a552670ceef
Figure S1. The four plasmids used in this study. A) The control plasmid contains the PSSEJ/GFP and Plac/DsRed genetic circuits as well as chloramphenicol resistance and the... -
Antimicrobial and antioxidant phytochemicals in leaf extracts of <i>Bergenia ...
Phenolic and flavonoid contents in leaf extracts of Bergenialigulata have been analysed for their contribution in antimicrobial and antioxidant activities. The extracts were... -
Additional file 2: of Estimating the costs for the treatment of abortion comp...
This questionnaire was designed to collect indirect costs borne by hospital facilities in treating patients. (PDF 327Â kb)
